Download PTU (I.K. Gujral Punjab Technical University Jalandhar (IKGPTU) M.Pharma 2020 March (Master of Pharmacy) 1st Sem 74676 Advanced Pharmacology I Previous Question Paper
Roll No. Total No. of Pages : 02
Total No. of Questions : 06
M. Pharmacy (Pharmacology) (2017 & Onwards) (Sem.?1)
ADVANCED PHARMACOLOGY-I
Subject Code : MPL-102T
M.Code : 74676
Time : 3 Hrs. Max. Marks : 75
INSTRUCTIONS TO CANDIDATES :
1. Attempt any FIVE questions out of SIX questions.
2. Each question carries FIFTEEN marks.
1. Write notes on following :
a. Explain neurochemical basis of Schizophrenia. Discuss the clinical status of atypical
antipsychotics. (10)
b. Write a short note on antiplatelet drugs. (5)
2. Discuss the mechanism of action, adverse effects and clinical status of the following
drugs :
a. Nitroglycerine (5)
b. Atorvastatin (5)
c. Lignocaine (5)
3. a. Discuss various agents affecting neuromuscular junction. (8)
b. Elaborate the significance of protein binding. (7)
4. Discuss briefly :
a. Steps involved in adrenergic neurotransmission (5)
b. Therapeutic status of Cholinesterase inhibitors (5)
c. Class II antiarrhythmic agents (5)
FirstRanker.com - FirstRanker's Choice
1 | M-74676 (S31)-649
Roll No. Total No. of Pages : 02
Total No. of Questions : 06
M. Pharmacy (Pharmacology) (2017 & Onwards) (Sem.?1)
ADVANCED PHARMACOLOGY-I
Subject Code : MPL-102T
M.Code : 74676
Time : 3 Hrs. Max. Marks : 75
INSTRUCTIONS TO CANDIDATES :
1. Attempt any FIVE questions out of SIX questions.
2. Each question carries FIFTEEN marks.
1. Write notes on following :
a. Explain neurochemical basis of Schizophrenia. Discuss the clinical status of atypical
antipsychotics. (10)
b. Write a short note on antiplatelet drugs. (5)
2. Discuss the mechanism of action, adverse effects and clinical status of the following
drugs :
a. Nitroglycerine (5)
b. Atorvastatin (5)
c. Lignocaine (5)
3. a. Discuss various agents affecting neuromuscular junction. (8)
b. Elaborate the significance of protein binding. (7)
4. Discuss briefly :
a. Steps involved in adrenergic neurotransmission (5)
b. Therapeutic status of Cholinesterase inhibitors (5)
c. Class II antiarrhythmic agents (5)
2 | M-74676 (S31)-649
5. Justify the use of the following drugs :
a. Diuretics in hypertension (5)
b. Vasodilators in congestive heart failure (5)
c. GABAergic drugs in anxiety (5)
6. Discuss Briefly :
a. Status of newer antiepileptic drugs (8)
b. Management of Congestive heart failure (7)
NOTE : Disclosure of Identity by writing Mobile No. or Making of passing request on any
page of Answer Sheet will lead to UMC against the Student.
FirstRanker.com - FirstRanker's Choice
This post was last modified on 31 March 2020